Evidence map›Paper›PMID 26015290›Full record

ArticleJournal of biomedical materials research. Part A2015

Mesenchymal stem cell response to topographically modified CoCrMo.

Niall Logan, Laurent Bozec, Alison Traynor, Peter Brett

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mesenchymal stem cell response to topographically modified CoCrMo.Journal of biomedical materials research. Part A · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Niall LoganBiomaterials and Tissue Engineering, University College London, Eastman Dental Institute, London, WC1X 8LD, United Kingdom.ORCID http://orcid.org/0000-0001-7082-2657
Laurent BozecBiomaterials and Tissue Engineering, University College London, Eastman Dental Institute, London, WC1X 8LD, United Kingdom.
Alison TraynorCorin Ltd, Cirencester, Gloucestershire, Gl7 1YJ, United Kingdom.
Peter BrettBiomaterials and Tissue Engineering, University College London, Eastman Dental Institute, London, WC1X 8LD, United Kingdom.
Eastman Dental Hospital · GBCorin (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface roughness on implant materials has been shown to be highly influential on the behavior of osteogenic cells. Four surface topographies were engineered on cobalt chromium molybdenum (CoCrMo) in order to examine this influence on human mesenchymal stem cells (MSC). These treatments were smooth polished (SMO), acid etched (AE) using HCl 7.4% and H2SO4 76% followed by HNO3 30%, sand blasted, and acid etched using either 50 μm Al2O3 (SLA50) or 250 μm Al2 O3 grit (SLA250). Characterization of the surfaces included energy dispersive X-ray analysis (EDX), contact angle, and surface roughness analysis. Human MSCs were cultured onto the four CoCrMo substrates and markers of cell attachment, retention, proliferation, cytotoxicity, and osteogenic differentiation were studied. Residual aluminum was observed on both SLA surfaces although this appeared to be more widely spread on SLA50, whilst SLA250 was shown to have the roughest topography with an Ra value greater than 1 μm. All substrates were shown to be largely non-cytotoxic although both SLA surfaces were shown to reduce cell attachment, whilst SLA50 also delayed cell proliferation. In contrast, SLA250 stimulated a good rate of proliferation resulting in the largest cell population by day 21. In addition, SLA250 stimulated enhanced cell retention, calcium deposition, and hydroxyapatite formation compared to SMO (p < 0.05). The enhanced response stimulated by SLA250 surface modification may prove advantageous for increasing the bioactivity of implants formed of CoCrMo.

Indexed as

Biocompatible MaterialsCell DifferentiationCell ProliferationCells, CulturedChromiumCobaltDurapatiteHumansMesenchymal Stem CellsMolybdenumOsteogenesisSurface PropertiesBiocompatible MaterialsChromiumCobaltDurapatiteMolybdenumadhesioncobalt alloymesenchymal stem cellsosteogenic differentiationSLA

Identifiers

PMID26015290
PMCPMC4975717
OpenAlexW1828524748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.